Other
Other income, net (Note 6)
Year-over-year, this metric grew by 90.6%, from -$339M to -$32M. Over 2 years (FY 2023 to FY 2025), Other income, net (Note 6) shows a downward trend with a -20.9% CAGR.
Analysis
StatementIncome Statement
SectionOther
CategoryProfitability
SignalContext dependent
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026
How to read this metric
An increase indicates positive contributions from non-core activities like investment gains or favorable currency impacts, while a decrease suggests losses from these peripheral financial items.
Detailed definition
This metric represents the net impact of financial activities that fall outside of a company's core pharmaceutical opera...
Peer comparison
Peers in the pharmaceutical industry often report similar line items, though the magnitude varies based on the size of their cash reserves and the extent of their strategic investment portfolios.
Metric ID:
other_other_nonoperating_income_expenseHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2M | $409M | -$649M | -$284M | $140M | $413M | $116M | $258M | $371M | -$81M | -$273M | -$234M | -$305M | -$339M | -$494M | $108M | $0 | -$32M |
| QoQ Change | — | >999% | -258.7% | +56.2% | +149.3% | +195.0% | -71.9% | +122.4% | +43.8% | -121.8% | -237.0% | +14.3% | -30.3% | -11.1% | -45.7% | +121.9% | -100.0% | — |
| YoY Change | — | — | — | <-999% | -65.8% | +163.6% | +140.8% | +84.3% | — | -119.6% | -335.3% | -190.7% | -182.2% | -318.5% | -81.0% | +146.2% | +100.0% | +90.6% |
Range-$649M – $413M
CAGR+92.0%
Avg YoY Growth<-999%
Median YoY Growth-73.4%
Other income, net (Note 6) at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's other income, net (note 6)?
- Bristol-Myers Squibb (BMY) reported other income, net (note 6) of -$32M in Q1 2026.
- How has Bristol-Myers Squibb's other income, net (note 6) changed year-over-year?
- Bristol-Myers Squibb's other income, net (note 6) increased by 90.6% year-over-year, from -$339M to -$32M.
- What is the long-term trend for Bristol-Myers Squibb's other income, net (note 6)?
- Over 2 years (2023 to 2025), Bristol-Myers Squibb's other income, net (note 6) has grown at a -20.9% compound annual growth rate (CAGR), from $1.16B to -$725M.
- What does other income, net (note 6) mean?
- The net result of financial gains and losses that are not related to the company's primary drug development and sales business.